Govt expert panel recommends regular market approval for Covishield, Covaxin – ET HealthWorld

Govt expert panel recommends regular market approval for Covishield, Covaxin – ET HealthWorld

By Payal Banerjee New Delhi, An expert panel of India’s central drug authority on Wednesday…

View More Govt expert panel recommends regular market approval for Covishield, Covaxin – ET HealthWorld
Full market approval for Covaxin, Covishield: Expert panel to meet today – ET HealthWorld

Full market approval for Covaxin, Covishield: Expert panel to meet today – ET HealthWorld

The subject expert committee (SEC), a body under the Drugs Controller General of India (DCGI),…

View More Full market approval for Covaxin, Covishield: Expert panel to meet today – ET HealthWorld
Media reports on expired Covid vaccines being used in India false, misleading: Health ministry – ET HealthWorld

Media reports on expired Covid vaccines being used in India false, misleading: Health ministry – ET HealthWorld

NEW DELHI: The Union health ministry on Monday dismissed media reports alleging that expired vaccines…

View More Media reports on expired Covid vaccines being used in India false, misleading: Health ministry – ET HealthWorld
India’s Serum Institute applies for full approval of Covishield vaccine – ET HealthWorld

India’s Serum Institute applies for full approval of Covishield vaccine – ET HealthWorld

BENGALURU: Serum Institute Of India has applied to the country’s drug regulator and the health…

View More India’s Serum Institute applies for full approval of Covishield vaccine – ET HealthWorld
Covid: 3rd dose will be of same vaccine as two earlier shots – ET HealthWorld

Covid: 3rd dose will be of same vaccine as two earlier shots – ET HealthWorld

NEW DELHI: Nearly three crore health and frontline workers will be eligible in January for…

View More Covid: 3rd dose will be of same vaccine as two earlier shots – ET HealthWorld
Lancet study stating that protection offered by Covishield declines after 3 months is misquoted, say experts – ET HealthWorld

Lancet study stating that protection offered by Covishield declines after 3 months is misquoted, say experts – ET HealthWorld

NEW DELHI: The Lancet study, which reportedly states that the protection offered by the Oxford…

View More Lancet study stating that protection offered by Covishield declines after 3 months is misquoted, say experts – ET HealthWorld
Morning Digest | Maharashtra tally at 10 after Mumbai reports first two cases of Omicron; Lok Sabha condemns Nagaland killings, demands compensation for victims, and more

Morning Digest | Maharashtra tally at 10 after Mumbai reports first two cases of Omicron; Lok Sabha condemns Nagaland killings, demands compensation for victims, and more

Two fully vaccinated persons who returned from abroad last month have tested positive for the…

View More Morning Digest | Maharashtra tally at 10 after Mumbai reports first two cases of Omicron; Lok Sabha condemns Nagaland killings, demands compensation for victims, and more
Covishield current monthly production capacity 250-275 mn doses, Covaxin 50-60 million doses: Govt – ET HealthWorld

Covishield current monthly production capacity 250-275 mn doses, Covaxin 50-60 million doses: Govt – ET HealthWorld

As communicated by the Serum Institute of India, the current monthly production capacity of anti-Covid…

View More Covishield current monthly production capacity 250-275 mn doses, Covaxin 50-60 million doses: Govt – ET HealthWorld
Covishield, Covaxin can protect against Omicron, claim experts – ET HealthWorld

Covishield, Covaxin can protect against Omicron, claim experts – ET HealthWorld

PUNE: Covishield and Covaxin jabs can prevent hospitalisation or death that may result from the…

View More Covishield, Covaxin can protect against Omicron, claim experts – ET HealthWorld
Government nod to commercial export of Covishield, Covaxin in view of sufficient stock – ET HealthWorld

Government nod to commercial export of Covishield, Covaxin in view of sufficient stock – ET HealthWorld

The Union government has allowed commercial export of Covishield and Covaxin considering the sufficient stock…

View More Government nod to commercial export of Covishield, Covaxin in view of sufficient stock – ET HealthWorld
‘Early vaccine recipients like elderly, medical staff with short jab gap need booster’ – ET HealthWorld

‘Early vaccine recipients like elderly, medical staff with short jab gap need booster’ – ET HealthWorld

MUMBAI: While debating on booster shots, the central health authorities should consider that early recipients-senior…

View More ‘Early vaccine recipients like elderly, medical staff with short jab gap need booster’ – ET HealthWorld